File Download
  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Article: Final results of a phase 1b 28-day study of ABI-H0731, a novel core inhibitor, in non-cirrhotic viremic subjects with chronic hepatitis B

TitleFinal results of a phase 1b 28-day study of ABI-H0731, a novel core inhibitor, in non-cirrhotic viremic subjects with chronic hepatitis B
Authors
Issue Date2018
PublisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/
Citation
The American Association for the Study of Liver Diseases (AASLD) Liver Meeting, San Francisco, USA, 9-13 November 2018. Abstracts in Hepatology, 2018, v. 68 n. 1, Suppl., p. 46A-47A How to Cite?
DescriptionOral Abstract - no. 73
Persistent Identifierhttp://hdl.handle.net/10722/275326
ISSN
2019 Impact Factor: 14.679
2015 SCImago Journal Rankings: 4.752

 

DC FieldValueLanguage
dc.contributor.authorYuen, RMF-
dc.contributor.authorAgarwal, K-
dc.contributor.authorGane, EJ-
dc.contributor.authorSchwabe, .C-
dc.contributor.authorAhn, SH-
dc.contributor.authorKim, DJ-
dc.contributor.authorLim, YS-
dc.contributor.authorCheng, W-
dc.contributor.authorSievert, W-
dc.contributor.authorVisvanathan, K-
dc.contributor.authorRuby, E-
dc.contributor.authorLiaw, S-
dc.contributor.authorYan, R-
dc.contributor.authorConnelly, E-
dc.contributor.authorCai, DW-
dc.contributor.authorHuang, Q-
dc.contributor.authorColonno, R-
dc.contributor.authorLopatin, UA-
dc.date.accessioned2019-09-10T02:40:18Z-
dc.date.available2019-09-10T02:40:18Z-
dc.date.issued2018-
dc.identifier.citationThe American Association for the Study of Liver Diseases (AASLD) Liver Meeting, San Francisco, USA, 9-13 November 2018. Abstracts in Hepatology, 2018, v. 68 n. 1, Suppl., p. 46A-47A-
dc.identifier.issn0270-9139-
dc.identifier.urihttp://hdl.handle.net/10722/275326-
dc.descriptionOral Abstract - no. 73-
dc.languageeng-
dc.publisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/-
dc.relation.ispartofHepatology-
dc.relation.ispartofAASLD (American Association for the Study of Liver Diseases) Liver Meeting, 2018-
dc.titleFinal results of a phase 1b 28-day study of ABI-H0731, a novel core inhibitor, in non-cirrhotic viremic subjects with chronic hepatitis B-
dc.typeArticle-
dc.identifier.emailYuen, RMF: mfyuen@hku.hk-
dc.identifier.authorityYuen, RMF=rp00479-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.hkuros304555-
dc.identifier.volume68-
dc.identifier.issue1, Suppl.-
dc.identifier.spage46A-
dc.identifier.epage47A-
dc.publisher.placeUnited States-
dc.identifier.issnl0270-9139-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats